Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M121,167Revenue $M20,063Net Margin (%)25.7Z-Score2.7
Enterprise Value $M133,894EPS $6.7Operating Margin %30.9F-Score5
P/E(ttm))22.7Cash Flow Per Share $6.7Pre-tax Margin (%)27.8Higher ROA y-yN
Price/Book5.210-y EBITDA Growth Rate %8.8Quick Ratio4.6Cash flow > EarningsY
Price/Sales5.85-y EBITDA Growth Rate %6.7Current Ratio5.0Lower Leverage y-yY
Price/Cash Flow13.3y-y EBITDA Growth Rate %8.4ROA % (ttm)7.5Higher Current Ratio y-yY
Dividend Yield %1.6Insider Buy (3m)0ROE % (ttm)21.4Less Shares Outstanding y-yN
Payout Ratio %36.0Shares Outstanding M761ROI % (ttm)8.2Gross Margin Increase y-yN

Gurus Latest Trades with AMGN

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AMGNVanguard Health Care Fund 2014-12-31 Reduce-0.51%$130.45 - $171.64
($155.84)
$ 152.26-2%Reduce -20.54%5,580,485
AMGNDaniel Loeb 2014-09-30 Add1.39%$115.39 - $144.01
($130.57)
$ 152.2617%Add 194.44%1,325,000
AMGNJean-Marie Eveillard 2014-09-30 Buy 0.25%$115.39 - $144.01
($130.57)
$ 152.2617%New holding, 714178 sh.714,178
AMGNKen Fisher 2014-09-30 Add0.02%$115.39 - $144.01
($130.57)
$ 152.2617%Add 83.59%156,629
AMGNRuane Cunniff 2014-09-30 Buy $115.39 - $144.01
($130.57)
$ 152.2617%New holding, 1617 sh.1,617
AMGNVanguard Health Care Fund 2014-09-30 Reduce-0.32%$115.39 - $144.01
($130.57)
$ 152.2617%Reduce -12.75%7,022,755
AMGNJohn Hussman 2014-09-30 Reduce-0.23%$115.39 - $144.01
($130.57)
$ 152.2617%Reduce -50%25,000
AMGNJoel Greenblatt 2014-09-30 Reduce-0.01%$115.39 - $144.01
($130.57)
$ 152.2617%Reduce -72.9%2,693
AMGNDaniel Loeb 2014-06-30 Buy 0.65%$110.29 - $126.07
($115.72)
$ 152.2632%New holding, 450000 sh.450,000
AMGNMario Gabelli 2014-06-30 Add0.02%$110.29 - $126.07
($115.72)
$ 152.2632%Add 85.28%60,335
AMGNJoel Greenblatt 2014-06-30 Buy 0.02%$110.29 - $126.07
($115.72)
$ 152.2632%New holding, 9938 sh.9,938
AMGNKen Fisher 2014-06-30 Add0.01%$110.29 - $126.07
($115.72)
$ 152.2632%Add 71.02%85,316
AMGNJohn Hussman 2014-06-30 Reduce-0.93%$110.29 - $126.07
($115.72)
$ 152.2632%Reduce -66.67%50,000
AMGNMario Gabelli 2014-03-31 Add0.01%$113.48 - $127.47
($121.04)
$ 152.2626%Add 37.87%32,565
AMGNKen Fisher 2014-03-31 Add0.01%$113.48 - $127.47
($120.95)
$ 152.2626%Add 754.67%49,887
AMGNDodge & Cox 2014-03-31 Reduce$113.48 - $127.47
($121.04)
$ 152.2626%Reduce -22.59%105,757
AMGNPRIMECAP Management 2014-03-31 Reduce-0.46%$113.48 - $127.47
($121.04)
$ 152.2626%Reduce -9.42%32,161,744
AMGNVanguard Health Care Fund 2014-03-31 Reduce-0.2%$113.48 - $127.47
($120.95)
$ 152.2626%Reduce -6.4%8,213,855
AMGNJohn Hussman 2014-03-31 Reduce-0.2%$113.48 - $127.47
($120.95)
$ 152.2626%Reduce -14.29%150,000
AMGNJoel Greenblatt 2014-03-31 Sold Out -0.06%$113.48 - $127.47
($121.04)
$ 152.2626%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AMGN is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
AMGN Ken Fisher 2014-12-31154,4390.020.05-1.4%
AMGN Ruane Cunniff 2014-09-301,61700New Buy
AMGN Jean-Marie Eveillard 2014-09-30714,1780.090.25New Buy
AMGN Daniel Loeb 2014-09-301,325,0000.172.1+194.44%
AMGN Ken Fisher 2014-09-30156,6290.020.05+83.59%
AMGN PRIMECAP Management 2014-09-3031,793,8734.184.8-0.19%
AMGN Mario Gabelli 2014-09-3059,9500.010.05-0.64%
AMGN Vanguard Health Care Fund 2014-09-307,022,7550.922.5-12.75%
AMGN Dodge & Cox 2014-09-3072,9070.010.01-15.08%
AMGN John Hussman 2014-09-3025,00000.3-50%
AMGN Joel Greenblatt 2014-09-302,69300-72.9%
AMGN Mark Hillman 2013-12-317,91201.4-1.95%
Premium Most recent portfolio changes are included for Premium Members only!


AMGN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
de Carbonnel FrancoisDirector 2014-12-03Sell3,000$168.01-6.93view
Patton Cynthia MSVP & CCO 2014-08-05Sell2,644$127.9722.19view
Harper Sean EEVP, Research & Development 2014-08-05Sell14,000$127.2922.85view
Dittrich Thomas J.W.VP, Finance & CAO 2014-05-21Sell4,130$112.8338.59view
Bradway Robert AChairman, CEO and President 2014-05-12Buy894$111.7739.9view
Michael A KellyActing CFO 2014-04-28Sell2,065$110.4541.58view
Piacquad DavidSVP, Business Development 2014-03-10Sell0$041.58view
de Carbonnel FrancoisDirector 2014-03-06Sell1,000$126.6923.43view
HENDERSON REBECCA MDirector 2014-02-13Sell20,000$123.5326.58view
Michael A KellyActing CFO 2014-01-10Sell0$026.58view

Press Releases about AMGN :

    Quarterly/Annual Reports about AMGN:

    News about AMGN:

    Articles On GuruFocus.com
    New Guru Jana Partners' Newest Stock Buys Jan 22 2015 
    Pharmaceutical Companies Amgen and Kite Partner for Cancer Therapy Jan 07 2015 
    Druckenmiller Adds Healthcare Stocks to Portfolio Dec 15 2014 
    Endonovo Therapeutics Receives Final Commissioned Report Recommendations Regarding FDA Regulatory Pa Dec 02 2014 
    Dividend Aristocrats In Focus Part 45: AbbVie Nov 24 2014 
    Amgen: Stronger Drug Portfolio with Acquisition Oct 28 2014 
    Daniel Loeb Comments on Amgen Inc Oct 22 2014 
    Third Point Q3 2014 Investor Letter Oct 22 2014 
    Amgen: Stronger Drug Portfolio with Acquisition Sep 22 2014 
    Insider Buys at Halozyme Look to Improve Stock Outlook Sep 18 2014 


    More From Other Websites
    Amgen, The Familial Hypercholesterolemia Foundation And Stanford Medicine Launch FIND FH™... Jan 29 2015
    Amgen, The Familial Hypercholesterolemia Foundation And Stanford Medicine Launch FIND FH™... Jan 29 2015
    AMGEN SUBMITS APPLICATIONS IN THE US AND EUROPE FOR KYPROLIS® (CARFILZOMIB) FOR THE TREATMENT OF... Jan 29 2015
    Wednesday's Market Recap Jan 28 2015
    Correction: Earns-Amgen story Jan 28 2015
    Correction: Earns-Amgen story Jan 28 2015
    Wait, I Thought Amgen Reported Solid Earnings? Jan 28 2015
    Amgen (AMGN) Stock Declines Today Despite Earnings Beat Jan 28 2015
    Amgen Beats on Q4 Earnings & Revenues, Maintains Outlook - Analyst Blog Jan 28 2015
    Amgen (AMGN) Earnings Report: Q4 2014 Conference Call Transcript Jan 28 2015
    Amgen Profit Rises 27% on Higher Sales of Key Drugs Jan 27 2015
    Amgen tops Street 4Q forecasts Jan 27 2015
    Amgen tops Street 4Q forecasts Jan 27 2015
    Amgen fourth-quarter earnings, revenue beat estimates Jan 27 2015
    Amgen Beats Q4 Expectations Jan 27 2015
    Amgen profit tops expectations on Enbrel sales, tax credit Jan 27 2015
    Stocks Weaken Late; Apple Jumps After Hours Jan 27 2015
    Amgen Inc Earnings Call scheduled for 5:00 pm ET today Jan 27 2015
    After-hours buzz: AT&T, Apple, Yahoo & more Jan 27 2015
    Amgen (AMGN) Stock Rises in After-Hours Trading Today on Fourth-Quarter Earnings Beat Jan 27 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK